Black and Hispanic patients were more likely than white patients to develop a wide array of lasting symptoms and conditions after a COVID-19 diagnosis, according to a new study led by Weill Cornell Medicine and NewYork-Presbyterian investigators.
A new screening tool identified roughly half of primary care patients with chronic obstructive pulmonary disorder who could benefit from available treatments, according to a nationwide study.
An experimental contraceptive drug candidate developed by Weill Cornell Medicine investigators temporarily stops sperm in their tracks and prevents pregnancies in preclinical models.
Two new grants from the Leukemia & Lymphoma Society will support Weill Cornell Medicine’s pathbreaking research on the origins of lymphomas and on treatments that exploit these cancers’ biological vulnerabilities.
Surgery that removes only a portion of one of the five lobes that comprise a lung is as effective as the traditional surgery that removes an entire lobe for certain patients with early-stage lung cancer, a new study has found.
The $3.5 million grant will go toward the improvement of screening and preventive treatment of cervical cancer for women living with HIV in low-resource countries.
A new Weill Cornell Medicine study solves a 50-year mystery and suggests that faulty mRNA modification may underlie some autoimmune and inflammatory disorders.
A new center at Cornell will fight the rise of antibiotic resistance, a global health challenge that threatens to reverse critical advances in modern medicine.
Twelve Cornell and Weill Cornell Medicine faculty members – six of whom are also Cornell alumni – have been elected fellows of the American Association for the Advancement of Science, the world’s largest general scientific society.
